PTKFY:OTCMKTS
PT Kalbe Farma Unsponsored Indonesia ADR
8,50Â $
0,00%
(0,00) 1 p
12. okt, 10:22:09 GMT −4 · USD
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse PTKFY põhistatistika genereerimine…
Turu kapit.
31,60Â trln
Keskm. maht
1,94Â tuh
Maht
1,43Â tuh
52 näd kõrgeim
16,36Â $
52 näd madalaim
7,63Â $
Beeta
0,09
Käibivad aktsiad
234,07Â mln
Töötajate arv
13Â tuh
Turu kapit.
31,60Â trln
Keskm. maht
1,94Â tuh
Maht
1,43Â tuh
52 näd kõrgeim
16,36Â $
52 näd madalaim
7,63Â $
Beeta
0,09
Käibivad aktsiad
234,07Â mln
Töötajate arv
13Â tuh
Uudised
Veebiallikatest ja uudistepartneritelt
ad-hoc-news.de
·
11 tunni eest
Buyback plans and results shaped Kalbe Farma stock review
ad-hoc-news.de
·
1 päeva eest
Kalbe Farma stock falls 14.56 percent to IDR 675.00
ad-hoc-news.de
·
1 päeva eest
Indo Premier sees Kalbe Farma stock earnings beating estimates
ad-hoc-news.de
·
2 päeva eest
Kalbe Farma launches IDR 500 billion buyback while Kiwoom targets Kalbe Farma stock
Profiil
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
Teave üksuse PT Kalbe Farma Unsponsored Indonesia ADR kohta